Essential Thrombocythemia
Showing NaN - NaN of 11
Myelofibrosis, Essential Thrombocythemia, MPN Trial in New York (Peptide-based vaccine, Poly ICLC)
Not yet recruiting
- Myelofibrosis
- +2 more
- Peptide-based vaccine
- Poly ICLC
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jun 7, 2022
Essential Thrombocythemia Trial in Worldwide (IMG-7289)
Active, not recruiting
- Essential Thrombocythemia
-
Jacksonville, Florida
- +25 more
Apr 15, 2022
Essential Thrombocythemia Trial in Worldwide (Ropeginterferon alfa-2b, Anagrelide)
Recruiting
- Essential Thrombocythemia
- Ropeginterferon alfa-2b
- Anagrelide
-
Phoenix, Arizona
- +60 more
Dec 30, 2021
Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide
Completed
- Primary Myelofibrosis
- +4 more
-
Scottsdale, Arizona
- +21 more
Jan 18, 2021
Research Tissue Bank
Completed
- Myelofibrosis
- +3 more
-
Palo Alto, California
- +10 more
Jul 2, 2019
Patients With Myeloproliferative Disorders
Completed
- Myeloproliferative Disease
- +4 more
-
Scottsdale, Arizona
- +21 more
Dec 12, 2018
Polycythemia Vera or Essential Thrombocythemia Patients
Completed
- Polycythemia Vera
- Essential Thrombocythemia
- Blood specimen
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jan 17, 2018
Familial Myeloproliferative Disorders
Completed
- Polycythemia Vera
- +2 more
-
Washington, D.C., District of Columbia
- +5 more
Sep 1, 2017
Myelofibrosis, Essential Thrombocythemia, Polycythemia Vera Trial in United States (CEP-701 (Lestaurtinib))
Unknown status
- Myelofibrosis
- +2 more
- CEP-701 (Lestaurtinib)
-
Palo Alto, California
- +6 more
Nov 24, 2014
Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +84 more
- sunitinib malate
- +2 more
-
Los Angeles, California
- +10 more
Mar 14, 2014